FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2047822962> ?p ?o ?g. }

• W2047822962 endingPage "1090" @default.
• W2047822962 startingPage "1080" @default.
• W2047822962 abstract "In the absence of an adequate ipsilateral greater saphenous vein, various alternative conduits have been used for the performance of lower extremity revascularization. In this study we compared the effectiveness of all-autogenous arm vein bypass grafts with that of prosthetic grafts.Seven hundred forty lower extremity revascularization procedures (506 arm vein, 234 prosthetic) performed between 1990 and 1999 were followed prospectively by means of a computerized vascular registry.Bypass graft configurations were femoro-above-knee-popliteal (26 arm vein, 100 prosthetic); femoro-below-knee-popliteal (38 arm vein, 29 prosthetic); femorotibial (174 arm vein, 55 prosthetic); femoropedal (23 arm vein, 2 prosthetic); popliteotibial/pedal (101 arm vein, 1 prosthetic); and extension jump grafts (144 arm vein, 47 prosthetic). The indications for surgery were limb salvage (98.0% arm vein, 89.7% prosthetic) and disabling claudication (2.0% arm vein, 10.3% prosthetic). The mean follow-up was 23.4 months (range, 1 month-7.4 years). Overall patient survival at 4 years was 54% (arm vein) and 69% (prosthetic). Cumulative patency varied with graft configuration. The 1-year primary patency rates for femorotibial grafts were 81.6% +/- 3.6% (arm vein) and 58.0% +/- 8.4% (prosthetic); the 3-year rates were 68.3% +/- 6.1% (arm vein) and 41.1% +/- 9.8% (prosthetic) (P<.01). The 1-year limb salvage rates for femorotibial grafts were 91.1% +/- 2.8% (arm vein) and 69.1% +/- 8. 8% (prosthetic); the 3-year rates were 81.4% +/- 5.6% (arm vein) and 63.2% +/- 10.3% (prosthetic) (P =.02). The 1-year primary patency rates for femoro-below-knee-popliteal grafts were 92.9% +/- 5.1% (arm vein) and 83.4% +/- 8.0% (prosthetic); the 3-year rates were 72.8% +/- 10.1% (arm vein) and 55.5% +/- 12.1% (prosthetic) (P=.05). The 1-year limb salvage rates for femoro-below-knee-popliteal grafts were 100% (arm vein) and 91.3% +/- 7.0% (prosthetic); the 3-year rates were 94.7% +/- 7.3% (arm vein) and 75.3% +/- 14.6% (prosthetic) (P = NS).In this study autogenous arm vein grafts demonstrated increased patency and limb salvage, compared with prosthetic grafts. These increases achieved statistical significance in the femoro-below-knee-popliteal and femorotibial configurations. An effort to use an all-autogenous vein conduit is justified on the basis of these results; however, if no autogenous vein is available, prosthetic grafts provide a reasonable alternative to primary amputation." @default.
• W2047822962 created "2016-06-24" @default.
• W2047822962 creator A5023816128 @default.
• W2047822962 creator A5027783423 @default.
• W2047822962 creator A5034213693 @default.
• W2047822962 creator A5057311813 @default.
• W2047822962 creator A5058803170 @default.
• W2047822962 creator A5059620619 @default.
• W2047822962 creator A5060522857 @default.
• W2047822962 creator A5071810251 @default.
• W2047822962 date "2000-12-01" @default.
• W2047822962 modified "2023-10-17" @default.
• W2047822962 title "A comparative study of alternative conduits for lower extremity revascularization: All-autogenous conduit versus prosthetic grafts" @default.
• W2047822962 cites W1972575470 @default.
• W2047822962 cites W1982385382 @default.
• W2047822962 cites W1983355568 @default.
• W2047822962 cites W1984123429 @default.
• W2047822962 cites W1984212474 @default.
• W2047822962 cites W1985193197 @default.
• W2047822962 cites W1999744917 @default.
• W2047822962 cites W2002465146 @default.
• W2047822962 cites W2016056120 @default.
• W2047822962 cites W2016929689 @default.
• W2047822962 cites W2018751773 @default.
• W2047822962 cites W2020811103 @default.
• W2047822962 cites W2033454961 @default.
• W2047822962 cites W2035956275 @default.
• W2047822962 cites W2037734896 @default.
• W2047822962 cites W2043517681 @default.
• W2047822962 cites W2045973896 @default.
• W2047822962 cites W2049456065 @default.
• W2047822962 cites W2053400043 @default.
• W2047822962 cites W2055850679 @default.
• W2047822962 cites W2063524432 @default.
• W2047822962 cites W2064909473 @default.
• W2047822962 cites W2066936633 @default.
• W2047822962 cites W2068982473 @default.
• W2047822962 cites W2072528323 @default.
• W2047822962 cites W2074741093 @default.
• W2047822962 cites W2081559561 @default.
• W2047822962 cites W2083054238 @default.
• W2047822962 cites W2119868260 @default.
• W2047822962 cites W2141783437 @default.
• W2047822962 cites W2144983193 @default.
• W2047822962 cites W2147458226 @default.
• W2047822962 cites W2165526229 @default.
• W2047822962 cites W4236929276 @default.
• W2047822962 doi "https://doi.org/10.1067/mva.2000.111279" @default.
• W2047822962 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11107079" @default.
• W2047822962 hasPublicationYear "2000" @default.
• W2047822962 type Work @default.
• W2047822962 sameAs 2047822962 @default.
• W2047822962 citedByCount "160" @default.
• W2047822962 countsByYear W20478229622012 @default.
• W2047822962 countsByYear W20478229622013 @default.
• W2047822962 countsByYear W20478229622014 @default.
• W2047822962 countsByYear W20478229622015 @default.
• W2047822962 countsByYear W20478229622016 @default.
• W2047822962 countsByYear W20478229622017 @default.
• W2047822962 countsByYear W20478229622018 @default.
• W2047822962 countsByYear W20478229622019 @default.
• W2047822962 countsByYear W20478229622020 @default.
• W2047822962 countsByYear W20478229622021 @default.
• W2047822962 countsByYear W20478229622022 @default.
• W2047822962 countsByYear W20478229622023 @default.
• W2047822962 crossrefType "journal-article" @default.
• W2047822962 hasAuthorship W2047822962A5023816128 @default.
• W2047822962 hasAuthorship W2047822962A5027783423 @default.
• W2047822962 hasAuthorship W2047822962A5034213693 @default.
• W2047822962 hasAuthorship W2047822962A5057311813 @default.
• W2047822962 hasAuthorship W2047822962A5058803170 @default.
• W2047822962 hasAuthorship W2047822962A5059620619 @default.
• W2047822962 hasAuthorship W2047822962A5060522857 @default.
• W2047822962 hasAuthorship W2047822962A5071810251 @default.
• W2047822962 hasBestOaLocation W20478229621 @default.
• W2047822962 hasConcept C141071460 @default.
• W2047822962 hasConcept C164705383 @default.
• W2047822962 hasConcept C2777202286 @default.
• W2047822962 hasConcept C2777466421 @default.
• W2047822962 hasConcept C2778715743 @default.
• W2047822962 hasConcept C2778963770 @default.
• W2047822962 hasConcept C2779464278 @default.
• W2047822962 hasConcept C3018348675 @default.
• W2047822962 hasConcept C500558357 @default.
• W2047822962 hasConcept C71924100 @default.
• W2047822962 hasConceptScore W2047822962C141071460 @default.
• W2047822962 hasConceptScore W2047822962C164705383 @default.
• W2047822962 hasConceptScore W2047822962C2777202286 @default.
• W2047822962 hasConceptScore W2047822962C2777466421 @default.
• W2047822962 hasConceptScore W2047822962C2778715743 @default.
• W2047822962 hasConceptScore W2047822962C2778963770 @default.
• W2047822962 hasConceptScore W2047822962C2779464278 @default.
• W2047822962 hasConceptScore W2047822962C3018348675 @default.
• W2047822962 hasConceptScore W2047822962C500558357 @default.
• W2047822962 hasConceptScore W2047822962C71924100 @default.
• W2047822962 hasIssue "6" @default.
• W2047822962 hasLocation W20478229621 @default.
• W2047822962 hasLocation W20478229622 @default.

• next